Related references
Note: Only part of the references are listed.Cancer Statistics, 2021
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Omeprazole Inhibits Glioblastoma Cell Invasion and Tumor Growth
Un-Ho Jin et al.
CANCERS (2020)
Cyclin-dependent protein serine/threonine kinase inhibitors as anticancer drugs
Robert Roskoski
PHARMACOLOGICAL RESEARCH (2019)
Inhibition of pancreatic cancer Panc1 cell migration by omeprazole is dependent on aryl hydrocarbon receptor activation of JNK
Un-Ho Jin et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
The Genetic Landscape and Clonal Evolution of Breast Cancer Resistance to Palbociclib plus Fulvestrant in the PALOMA-3 Trial
Ben O'Leary et al.
CANCER DISCOVERY (2018)
Loss of the FAT1 Tumor Suppressor Promotes Resistance to CDK4/6 Inhibitors via the Hippo Pathway
Zhiqiang Li et al.
CANCER CELL (2018)
Polyclonal RB1 mutations and acquired resistance to CDK 4/6 inhibitors in patients with metastatic breast cancer
R. Condorelli et al.
ANNALS OF ONCOLOGY (2018)
Differential effects on lung and bone metastasis of breast cancer by Wnt signalling inhibitor DKK1
Xueqian Zhuang et al.
NATURE CELL BIOLOGY (2017)
Inhibitors of cyclin-dependent kinases as cancer therapeutics
Steven R. Whittaker et al.
PHARMACOLOGY & THERAPEUTICS (2017)
MONARCH 1, A Phase II Study of Abemaciclib, a CDK4 and CDK6 Inhibitor, as a Single Agent, in Patients with Refractory HR+/HER2- Metastatic Breast Cancer
Maura N. Dickler et al.
CLINICAL CANCER RESEARCH (2017)
Early Adaptation and Acquired Resistance to CDK4/6 Inhibition in Estrogen Receptor-Positive Breast Cancer
Maria Teresa Herrera-Abreu et al.
CANCER RESEARCH (2016)
Snail1-dependent p53 repression regulates expansion and activity of tumour-initiating cells in breast cancer
Ting Ni et al.
NATURE CELL BIOLOGY (2016)
AK-1, a specific SIRT2 inhibitor, induces cell cycle arrest by downregulating Snail in HCT116 human colon carcinoma cells
Min Gyeong Cheon et al.
CANCER LETTERS (2015)
Omeprazole Inhibits Pancreatic Cancer Cell Invasion through a Nongenomic Aryl Hydrocarbon Receptor Pathway
Un-Ho Jin et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2015)
The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study
Richard S. Finn et al.
LANCET ONCOLOGY (2015)
Targeting Cyclin-Dependent Kinases and Cell Cycle Progression in Human Cancers
Loredana Santo et al.
SEMINARS IN ONCOLOGY (2015)
The aryl hydrocarbon receptor ligand omeprazole inhibits breast cancer cell invasion and metastasis
Un-Ho Jin et al.
BMC CANCER (2014)
Acetylation of Snail Modulates the Cytokinome of Cancer Cells to Enhance the Recruitment of Macrophages
Dennis Shin-Shian Hsu et al.
CANCER CELL (2014)
A Snail1/Notch1 signalling axis controls embryonic vascular development
Zhao-Qiu Wu et al.
NATURE COMMUNICATIONS (2014)
The novel Aryl hydrocarbon receptor inhibitor biseugenol inhibits gastric tumor growth and peritoneal dissemination
De-Wei Lai et al.
ONCOTARGET (2014)
Cyclin D activates the Rb tumor suppressor by mono-phosphorylation
Anil M. Narasimha et al.
ELIFE (2014)
Cyclin-dependent kinases
Marcos Malumbres
GENOME BIOLOGY (2014)
Collective Invasion in Breast Cancer Requires a Conserved Basal Epithelial Program
Kevin J. Cheung et al.
CELL (2013)
Dioxin Receptor Expression Inhibits Basal and Transforming Growth Factor β-induced Epithelial-to-mesenchymal Transition
Eva M. Rico-Leo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
The epigenetics of epithelial-mesenchymal plasticity in cancer
Wai Leong Tam et al.
NATURE MEDICINE (2013)
Epithelial Plasticity: A Common Theme in Embryonic and Cancer Cells
M. Angela Nieto
SCIENCE (2013)
Pharmacokinetics and Pharmacodynamics of the Proton Pump Inhibitors
Jai Moo Shin et al.
JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY (2013)
Regulatory networks defining EMT during cancer initiation and progression
Bram De Craene et al.
NATURE REVIEWS CANCER (2013)
The tumor microenvironment at a glance
Frances R. Balkwill et al.
JOURNAL OF CELL SCIENCE (2012)
Canonical Wnt signaling regulates Slug activity and links epithelial-mesenchymal transition with epigenetic Breast Cancer 1, Early Onset (BRCA1) repression
Zhao-Qiu Wu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Aryl Hydrocarbon Receptor (AHR)-Active Pharmaceuticals Are Selective AHR Modulators in MDA-MB-468 and BT474 Breast Cancer Cells
Un-Ho Jin et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Expression of p16 and Retinoblastoma Determines Response to CDK4/6 Inhibition in Ovarian Cancer
Gottfried E. Konecny et al.
CLINICAL CANCER RESEARCH (2011)
Optimisation of breast cancer management in low-resource and middle-resource countries: executive summary of the Breast Health Global Initiative consensus, 2010
Benjamin O. Anderson et al.
LANCET ONCOLOGY (2011)
Omeprazole Inhibits Proliferation and Modulates Autophagy in Pancreatic Cancer Cells
Andrej Udelnow et al.
PLOS ONE (2011)
Epithelial-Mesenchymal Transitions in Development and Disease
Jean Paul Thiery et al.
CELL (2009)
Proton pump inhibitors induce apoptosis of human B-cell tumors through a caspase-independent mechanism involving reactive oxygen species
Angelo De Milito et al.
CANCER RESEARCH (2007)
Complex networks orchestrate epithelial-mesenchymal transitions
JP Thiery et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
Selective induction of apoptosis with proton pump inhibitor in gastric cancer cells
M Yeo et al.
CLINICAL CANCER RESEARCH (2004)
Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis
J Yang et al.
CELL (2004)
Progression to malignancy in the polyoma middle T oncoprotein mouse breast cancer model provides a reliable model for human diseases
EY Lin et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Epithelial-mesenchymal transitions in tumour progression
JP Thiery
NATURE REVIEWS CANCER (2002)
The snail superfamily of zinc-finger transcription factors
MA Nieto
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2002)
The transcription factor Snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression
A Cano et al.
NATURE CELL BIOLOGY (2000)
The transcription factor Snail is a repressor of E-cadherin gene expression in epithelial tumour cells
E Batlle et al.
NATURE CELL BIOLOGY (2000)
Share Paper
